Curasan AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other
pharmaceutical manufacturers in Europe:
Co Don AG
sales of 5.60 million Euro [US$6.25 million]
Biomed Lublin Wytwornia Surowic I Szczepionek SA
(36.34 million Polish New Zlotys [US$9.67 million]
based in France
(8.73 million Euro [US$9.74 million]
of which 72%
was Research & Development Tax Credit).
Curasan AG reported sales of 6.94 million Euro (US$7.75 million)
December of 2016.
increase of 23.5%
versus 2015, when the company's sales were 5.62 million Euro.